vs

Side-by-side financial comparison of MYRIAD GENETICS INC (MYGN) and Thryv Holdings, Inc. (THRY). Click either name above to swap in a different company.

MYRIAD GENETICS INC is the larger business by last-quarter revenue ($209.8M vs $167.7M, roughly 1.3× Thryv Holdings, Inc.). On growth, MYRIAD GENETICS INC posted the faster year-over-year revenue change (-0.4% vs -7.5%). Over the past eight quarters, MYRIAD GENETICS INC's revenue compounded faster (1.9% CAGR vs -13.5%).

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

Thryv Holdings, Inc. is a publicly traded software as a service (SaaS) company, providing customer relationship management and online reputation management software for small businesses. It has headquarters in Dallas, Texas, and operates in 48 states across the United States of America with more than 2,400 employees. The company began as a conglomerate of Yellow Pages companies. In June 2020, Thryv reported $1.3 billion in revenue over a twelve-month period.

MYGN vs THRY — Head-to-Head

Bigger by revenue
MYGN
MYGN
1.3× larger
MYGN
$209.8M
$167.7M
THRY
Growing faster (revenue YoY)
MYGN
MYGN
+7.2% gap
MYGN
-0.4%
-7.5%
THRY
Faster 2-yr revenue CAGR
MYGN
MYGN
Annualised
MYGN
1.9%
-13.5%
THRY

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
MYGN
MYGN
THRY
THRY
Revenue
$209.8M
$167.7M
Net Profit
$4.5M
Gross Margin
70.0%
65.2%
Operating Margin
-2.7%
37.3%
Net Margin
2.7%
Revenue YoY
-0.4%
-7.5%
Net Profit YoY
147.2%
EPS (diluted)
$-0.09
$0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MYGN
MYGN
THRY
THRY
Q1 26
$167.7M
Q4 25
$209.8M
$191.6M
Q3 25
$205.7M
$201.6M
Q2 25
$213.1M
$210.5M
Q1 25
$195.9M
$181.4M
Q4 24
$210.6M
$186.6M
Q3 24
$213.3M
$179.9M
Q2 24
$211.5M
$224.1M
Net Profit
MYGN
MYGN
THRY
THRY
Q1 26
$4.5M
Q4 25
$-9.7M
Q3 25
$-27.4M
$5.7M
Q2 25
$-330.5M
$13.9M
Q1 25
$-100.0K
$-9.6M
Q4 24
$7.9M
Q3 24
$-22.1M
$-96.1M
Q2 24
$-36.7M
$5.5M
Gross Margin
MYGN
MYGN
THRY
THRY
Q1 26
65.2%
Q4 25
70.0%
68.0%
Q3 25
69.9%
67.7%
Q2 25
71.2%
69.7%
Q1 25
68.5%
65.8%
Q4 24
71.7%
65.9%
Q3 24
70.2%
62.3%
Q2 24
69.6%
66.3%
Operating Margin
MYGN
MYGN
THRY
THRY
Q1 26
37.3%
Q4 25
-2.7%
5.3%
Q3 25
-11.3%
9.9%
Q2 25
-154.5%
14.0%
Q1 25
-14.8%
-1.7%
Q4 24
-18.6%
-3.9%
Q3 24
-9.4%
-49.2%
Q2 24
-17.3%
14.0%
Net Margin
MYGN
MYGN
THRY
THRY
Q1 26
2.7%
Q4 25
-5.0%
Q3 25
-13.3%
2.8%
Q2 25
-155.1%
6.6%
Q1 25
-0.1%
-5.3%
Q4 24
4.2%
Q3 24
-10.4%
-53.4%
Q2 24
-17.4%
2.5%
EPS (diluted)
MYGN
MYGN
THRY
THRY
Q1 26
$0.10
Q4 25
$-0.09
$-0.21
Q3 25
$-0.29
$0.13
Q2 25
$-3.57
$0.31
Q1 25
$0.00
$-0.22
Q4 24
$-0.47
$0.28
Q3 24
$-0.24
$-2.65
Q2 24
$-0.41
$0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MYGN
MYGN
THRY
THRY
Cash + ST InvestmentsLiquidity on hand
$149.6M
$8.0M
Total DebtLower is stronger
$119.9M
Stockholders' EquityBook value
$368.0M
$225.4M
Total Assets
$706.6M
$693.7M
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MYGN
MYGN
THRY
THRY
Q1 26
$8.0M
Q4 25
$149.6M
$10.8M
Q3 25
$145.4M
$11.6M
Q2 25
$74.4M
$10.8M
Q1 25
$91.8M
$11.0M
Q4 24
$102.4M
$16.3M
Q3 24
$99.9M
$12.5M
Q2 24
$97.3M
$15.5M
Total Debt
MYGN
MYGN
THRY
THRY
Q1 26
Q4 25
$119.9M
$253.5M
Q3 25
$119.5M
$268.2M
Q2 25
$275.6M
Q1 25
$299.0M
Q4 24
$284.3M
Q3 24
$307.8M
Q2 24
$342.1M
Stockholders' Equity
MYGN
MYGN
THRY
THRY
Q1 26
$225.4M
Q4 25
$368.0M
$218.1M
Q3 25
$372.8M
$221.1M
Q2 25
$388.1M
$214.9M
Q1 25
$704.9M
$193.2M
Q4 24
$701.1M
$196.9M
Q3 24
$731.7M
$94.5M
Q2 24
$740.5M
$183.1M
Total Assets
MYGN
MYGN
THRY
THRY
Q1 26
$693.7M
Q4 25
$706.6M
$688.6M
Q3 25
$728.1M
$701.8M
Q2 25
$677.3M
$687.7M
Q1 25
$1.0B
$703.7M
Q4 24
$1.0B
$712.2M
Q3 24
$1.1B
$654.8M
Q2 24
$1.1B
$785.5M
Debt / Equity
MYGN
MYGN
THRY
THRY
Q1 26
Q4 25
0.33×
1.16×
Q3 25
0.32×
1.21×
Q2 25
1.28×
Q1 25
1.55×
Q4 24
1.44×
Q3 24
3.26×
Q2 24
1.87×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MYGN
MYGN
THRY
THRY
Operating Cash FlowLast quarter
$10.6M
Free Cash FlowOCF − Capex
$-5.5M
FCF MarginFCF / Revenue
-3.3%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$43.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MYGN
MYGN
THRY
THRY
Q1 26
Q4 25
$10.6M
$22.2M
Q3 25
$21.1M
$22.2M
Q2 25
$-13.6M
$29.6M
Q1 25
$-16.3M
$-10.5M
Q4 24
$6.6M
$26.1M
Q3 24
$700.0K
$36.0M
Q2 24
$2.6M
$22.2M
Free Cash Flow
MYGN
MYGN
THRY
THRY
Q1 26
$-5.5M
Q4 25
$12.3M
Q3 25
$14.6M
Q2 25
$21.8M
Q1 25
$-17.6M
Q4 24
$17.3M
Q3 24
$27.5M
Q2 24
$13.3M
FCF Margin
MYGN
MYGN
THRY
THRY
Q1 26
-3.3%
Q4 25
6.4%
Q3 25
7.2%
Q2 25
10.4%
Q1 25
-9.7%
Q4 24
9.3%
Q3 24
15.3%
Q2 24
5.9%
Capex Intensity
MYGN
MYGN
THRY
THRY
Q1 26
Q4 25
5.2%
Q3 25
3.8%
Q2 25
3.7%
Q1 25
3.9%
Q4 24
4.7%
Q3 24
4.7%
Q2 24
4.0%
Cash Conversion
MYGN
MYGN
THRY
THRY
Q1 26
Q4 25
Q3 25
3.93×
Q2 25
2.12×
Q1 25
Q4 24
3.32×
Q3 24
Q2 24
4.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MYGN
MYGN

Segment breakdown not available.

THRY
THRY

SaaS$116.7M70%
Other$50.9M30%

Related Comparisons